Fig. 3

Incidence of MACE in a Kaplan-Meier-Survival analysis. Comparing Group I, Group II and Group III according to the diabetes state; T2DM type 2 diabetes mellitus, nT2DM non-type 2 diabetes mellitus, MACE major adverse cardiovascular event.
Incidence of MACE in a Kaplan-Meier-Survival analysis. Comparing Group I, Group II and Group III according to the diabetes state; T2DM type 2 diabetes mellitus, nT2DM non-type 2 diabetes mellitus, MACE major adverse cardiovascular event.